The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1026263111 10262631 11 F 20131016 20160805 20140626 20160816 EXP US-SA-2013SA107554 AVENTIS 61.00 YR A F Y 0.00000 20160816 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1026263111 10262631 1 PS AUBAGIO TERIFLUNOMIDE 1 Oral U 4DP8ASA 202992 14 MG COATED TABLET QD
1026263111 10262631 2 SS AUBAGIO TERIFLUNOMIDE 1 Oral U UNKNNOWN 202992 14 MG COATED TABLET QD
1026263111 10262631 3 SS AUBAGIO TERIFLUNOMIDE 1 Oral U 4A66ASA 202992 14 MG COATED TABLET QD
1026263111 10262631 4 SS AUBAGIO TERIFLUNOMIDE 1 Oral U UNK 202992 14 MG COATED TABLET QD
1026263111 10262631 5 SS AUBAGIO TERIFLUNOMIDE 1 Oral U UNK 202992 14 MG COATED TABLET QOD
1026263111 10262631 6 SS AUBAGIO TERIFLUNOMIDE 1 Oral U UNKNOWN 202992 14 MG COATED TABLET QD
1026263111 10262631 7 SS AMPYRA DALFAMPRIDINE 1 Unknown U UNK 0 10 MG BID
1026263111 10262631 8 C TYLENOL ACETAMINOPHEN 1 0
1026263111 10262631 9 C VITAMIN D3 CHOLECALCIFEROL 1 0
1026263111 10262631 10 C COQ10 UBIDECARENONE 1 0
1026263111 10262631 11 C GLUCOSAMINE GLUCOSAMINE 1 0
1026263111 10262631 12 C OXYBUTYNIN OXYBUTYNIN 1 0
1026263111 10262631 13 C BENICAR OLMESARTAN MEDOXOMIL 1 0
1026263111 10262631 14 C DICLOFENAC SODIUM. DICLOFENAC SODIUM 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1026263111 10262631 1 Multiple sclerosis
1026263111 10262631 2 Multiple sclerosis
1026263111 10262631 3 Multiple sclerosis
1026263111 10262631 4 Multiple sclerosis
1026263111 10262631 5 Multiple sclerosis
1026263111 10262631 6 Multiple sclerosis
1026263111 10262631 7 Multiple sclerosis

Outcome of event

Event ID CASEID OUTC COD
1026263111 10262631 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1026263111 10262631 Alopecia
1026263111 10262631 Burning sensation
1026263111 10262631 Dizziness
1026263111 10262631 Drug dose omission
1026263111 10262631 Dyspepsia
1026263111 10262631 Fall
1026263111 10262631 Gait disturbance
1026263111 10262631 Headache
1026263111 10262631 Inappropriate schedule of drug administration
1026263111 10262631 Memory impairment
1026263111 10262631 Nasal obstruction
1026263111 10262631 Pain in extremity
1026263111 10262631 Stress
1026263111 10262631 Wrist fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1026263111 10262631 1 20130824 20140108 0
1026263111 10262631 2 20140111 201501 0
1026263111 10262631 3 20150213 0
1026263111 10262631 4 20130917 0
1026263111 10262631 5 201501 20150131 0
1026263111 10262631 6 20160714 0
1026263111 10262631 7 20101201 0